Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CTN-0109)

NIH RePORTER · NIH · N01 · $1,154,351 · view on reporter.nih.gov ↗

Abstract

Randomized, Placebo-Controlled Trial of Extended-Release Naltrexone and Monthly Extended-Release Buprenorphine for Cocaine Use Disorder (CURB-2) (CTN-0109)

Key facts

NIH application ID
10505737
Project number
75N95019D00013-0-759502100003-1
Recipient
THE EMMES COMPANY, LLC
Principal Investigator
Paul VanVeldhuisen
Activity code
N01
Funding institute
NIH
Fiscal year
2021
Award amount
$1,154,351
Award type
—
Project period
2021-07-01 → 2023-10-30